HIVENT PLUS Ipratropium / Salbutamol 2.50mg / 500mcg - 1 Nebule 2.5mL

Indications / Uses

HIVENT PLUS Ipratropium / Salbutamol Nebule is used for managing bronchospasm in chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. It provides relief from acute respiratory symptoms by relaxing airway muscles and reducing bronchial constriction. This combination medication is also indicated for asthma maintenance therapy and reversible airway obstruction management.

Formulation / Ingredients
HIVENT PLUS Ipratropium / Salbutamol Nebule contains: Ipratropium Bromide 500mcg + Salbutamol (as sulfate) 2.50mg per 2.5mL solution.

Side Effects

HIVENT PLUS Ipratropium / Salbutamol Nebule common side effects include: headache, tremor, nervousness, palpitations, and dry mouth. Less frequently reported reactions include throat irritation, muscle cramps, or paradoxical bronchospasm. Discontinue use immediately if chest pain or severe allergic reactions occur.

Directions and Dosage

• Adults & Adolescents (12+ years): 1 nebule (2.5mL) every 6-8 hours as needed
• Children 6-11 years: ½-1 nebule (1.25-2.5mL) every 6-8 hours as needed

Maximum daily dose: 4 nebules (10mL). Not recommended for children under 6 years. Use only during acute symptoms as directed.

Contraindications

Do not use with known hypersensitivity to atropine derivatives or similar bronchodilators. Avoid in cases of tachyarrhythmias, severe cardiac disorders, or uncontrolled hyperthyroidism.

Special Precautions

• Monitor for worsening respiratory symptoms or paradoxical bronchospasm
• Use cautiously in patients with cardiovascular diseases or glaucoma
• Ensure proper nebulizer cleaning to prevent contamination

Is it safe to take it with other medications?

May interact with beta-blockers reducing effectiveness. Concurrent use with other sympathomimetics may increase cardiovascular side effects.

How should I store it?

Store below 30°C in original packaging. Protect from light and moisture. Keep nebules sealed until use.

Used For

COPD, Asthma

Age

From 6 years